Henry Schein, Inc. (NASDAQ:HSIC) is one of the stocks highlighted as Jim Cramer responded to questions from Harvard Business ...

Henry Schein Inc (HSIC) reports robust global sales growth and strategic advancements, despite facing challenges in operating ...

Shares of Henry Schein Inc. jumped 10.78% to $71.61 Tuesday, on what proved to be an all-around rough trading session for the ...

Q3 2025 Management View Stanley Bergman, Executive Chairman & CEO, reported "sales growth accelerating in each of our ...

Q3 2025 Earnings Call November 4, 2025 8:00 AM ESTCompany ParticipantsGraham Stanley - VP of Investor Relations & ...

Henry Schein posted adjusted EPS of $1.38, beating market estimates of $1.28. The company's quarterly sales came in at $3.339 ...

VideaHealth, the leading dental AI platform, in collaboration with Henry Schein One, today announced the launch of the Impact Panel, a new enhancement within the Detect AI experience for Dentrix (R) ...

Henry Schein, Inc. recently reported third quarter 2025 results, showing year-over-year growth in both sales and net income, and raised its full-year 2025 earnings guidance to reflect stronger ...

Henry Schein lifts annual forecast on strong dental, medical equipment sales Medical equipment distributor Henry Schein raised its annual profit forecast after beating Wall Street estimates for ...

Covetrus Inc., a Portland-based animal health-health company, has sold a Massachusetts-based equine health division to online ...

Henry Schein ( HSIC) shares rose following the company's updated forecast for adjusted profit and sales growth for the year. The company revised its 2025 adjusted profit estimate to a range of $4.88 ...

Medical equipment distributor Henry Schein raised its annual profit forecast after beating Wall Street estimates for third-quarter results on Tuesday, driven by strong sales in its dental and medical ...